DR. ROBERT R REDFIELD, M.D.
Osteopathic Medicine at Greene St, Baltimore, MD
License number
Maryland D25013
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
22 S Greene St, Baltimore, MD 21201
Phone
(410) 706-4613
(410) 706-4619 (Fax)
(410) 706-4619 (Fax)
Personal information
See more information about ROBERT R REDFIELD at radaris.comName
Address
Phone
515 Warren St APT 12, Hvre De Grace, MD 21078
105 Cotswold Rd, Baltimore, MD 21210
258 Rodgers Forge Rd, Baltimore, MD 21212
142 Hopkins St, Govans, MD 21212
105 Cotswold Rd, Baltimore, MD 21210
Organization information
See more information about ROBERT R REDFIELD at bizstanding.comRobert R Redfield MD
29 S Greene St #300, Baltimore, MD 21201
Categories:
Infectious Disease Physicians & Surgeons
Phone:
(410) 328-5725 (Phone)
Professional information
Robert R Redfield, Baltimore MD
Specialties:
Infectious Disease Specialist
Address:
22 S Greene St, Baltimore, MD 21201
725 W Lombard St, Baltimore, MD 21201
725 W Lombard St, Baltimore, MD 21201
Education:
Georgetown University, School of Medicine - Doctor of Medicine
Walter Reed Army Medical Center - Fellowship - Infectious Disease (Internal Medicine)
Walter Reed Army Medical Center - Residency - Family Medicine
Walter Reed Army Medical Center - Fellowship - Infectious Disease (Internal Medicine)
Walter Reed Army Medical Center - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)
Robert Ray Redfield, Baltimore MD
Specialties:
Internal Medicine, Infectious Disease, Clinical & Laboratory Immunology, Forensic Pathology
Work:
University of Maryland
22 S Greene St, Baltimore, MD 21263 Univ. Of Md Medical Group
16 S Eutaw St, Baltimore, MD 21201 Univ. Of Md Medical Group
827 Linden Ave, Baltimore, MD 21201
22 S Greene St, Baltimore, MD 21263 Univ. Of Md Medical Group
16 S Eutaw St, Baltimore, MD 21201 Univ. Of Md Medical Group
827 Linden Ave, Baltimore, MD 21201
Education:
Georgetown University (1977)
Dr. Robert R Redfield, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
16 S Eutaw St SUITE 100, Baltimore 21201
(410) 328-1900 (Phone)
Institute Of Human Virology
29 S Greene St SUITE 300, Baltimore 21201
(410) 328-5725 (Phone)
22 S Greene St, Baltimore 21201
(410) 328-5793 (Phone), (410) 328-0248 (Fax)
(410) 328-1900 (Phone)
Institute Of Human Virology
29 S Greene St SUITE 300, Baltimore 21201
(410) 328-5725 (Phone)
22 S Greene St, Baltimore 21201
(410) 328-5793 (Phone), (410) 328-0248 (Fax)
Certifications:
Infectious Disease, 1982, Internal Medicine, 1980
Awards:
Healthgrades Honor Roll
Languages:
English, French, Spanish
Hospitals:
16 S Eutaw St SUITE 100, Baltimore 21201
22 S Greene St, Baltimore 21201
Institute Of Human Virology
29 S Greene St SUITE 300, Baltimore 21201
Maryland General Hospital
827 Linden Ave, Baltimore 21201
University of Maryland Medical Center
22 South Greene St, Baltimore 21201
22 S Greene St, Baltimore 21201
Institute Of Human Virology
29 S Greene St SUITE 300, Baltimore 21201
Maryland General Hospital
827 Linden Ave, Baltimore 21201
University of Maryland Medical Center
22 South Greene St, Baltimore 21201
Education:
Medical School
Georgetown University School Of Medicine
Graduated: 1977
Walter Reed Army Med Center
Graduated: 1978
Graduated: 1980
Graduated: 1982
Georgetown University School Of Medicine
Graduated: 1977
Walter Reed Army Med Center
Graduated: 1978
Graduated: 1980
Graduated: 1982
Compositions For Treating Viral Infections, And Methods Therefor
US Patent:
6479466, Nov 12, 2002
Filed:
Aug 11, 2000
Appl. No.:
09/637652
Inventors:
Robert R. Redfield - Baltimore MD
Alonso Heredia - Washington DC
Alonso Heredia - Washington DC
Assignee:
University of Maryland - Baltimore MD
University of Maryland Biotechnology Institute - Baltimore MD
University of Maryland Biotechnology Institute - Baltimore MD
International Classification:
A61K 3152
US Classification:
514 45, 514 46, 514 49, 514 50, 51426323, 51426332, 5142634, 514272
Abstract:
Methods and combinations of an agent that promotes DNA synthesis in a virally-targeted cell and a nucleoside analogue having antiviral activity are provided for treating a viral infection in a subject in need thereof. Such compositions are particularly effective where the subject has resistance to a nucleoside analogue, where the subject has resting cellular reservoirs of such a virus, or to induce a post-treatment period of replication incompetence of such a virus.
Synergistic Combinations Of Guanosine Analog Reverse Transcriptase Inhibitors And Inosine Monophosphate Dehydrogenese Inhibitors And Uses Therefor
US Patent:
6514979, Feb 4, 2003
Filed:
Mar 3, 1999
Appl. No.:
09/261712
Inventors:
David Margolis - Baltimore MD
Alonso Heredia - Washington DC
David Oldach - Towson MD
Robert Redfield - Baltimore MD
Alonso Heredia - Washington DC
David Oldach - Towson MD
Robert Redfield - Baltimore MD
Assignee:
University of Maryland Biotechnology Institute - College Park MD
International Classification:
A61K 3152
US Classification:
514261, 514266, 514470
Abstract:
Synergistic combinations of guanosine nucleoside analog reverse transcriptase inhibitors such as abacavir with inosine monophosphate dehydrogenase inhibitors such as mycophenolates, pharmaceutical compositions comprising such combinations, and therapeutic methods comprising administering the synergistic combinations to subjects in need thereof, for treating a viral infection, such as an HIV-1 infection.
Compositions For Inducing Increased Levels Of Beta-Chemokines And Methods Of Use Therefor
US Patent:
2006009, May 11, 2006
Filed:
Sep 12, 2003
Appl. No.:
10/527904
Inventors:
Robert Redfield - Baltimore MD, US
Anthony Amoroso - Baltimore MD, US
Charles Davis - Laurel MD, US
Alonso Heredia - Washington DC, US
Anthony Amoroso - Baltimore MD, US
Charles Davis - Laurel MD, US
Alonso Heredia - Washington DC, US
International Classification:
A61K 38/19, A61K 38/12, A61K 31/7076, A61K 39/395, A61K 31/551, A61K 31/522, A61K 31/355, A61K 31/19
US Classification:
424085100, 514045000, 514049000, 514220000, 514263320, 514291000, 514458000, 514557000, 514575000, 424145100
Abstract:
The present invention relates to compositions and methods for inducing increased levels and availability of β-chemokines by administering to a subject at least one G1 phase arresting compound, wherein the increased levels and availability of β-chemokines block chemokine/viral receptors thereby preventing or treating viral infections.
Compositions For Down-Regulation Of Ccr5 Expression And Methods Of Use Thereof
US Patent:
7863242, Jan 4, 2011
Filed:
Nov 16, 2005
Appl. No.:
11/281195
Inventors:
Robert R. Redfield - Baltimore MD, US
Anthony Amoroso - Baltimore MD, US
Charles E. Davis - Laurel MD, US
Alonso Heredia - Washington DC, US
Anthony Amoroso - Baltimore MD, US
Charles E. Davis - Laurel MD, US
Alonso Heredia - Washington DC, US
Assignee:
University of Maryland, Baltimore - Baltimore MD
International Classification:
A61K 38/00, A61K 31/445, A61K 31/33
US Classification:
514 12, 514315, 514183
Abstract:
The present invention relates to the downregulation of surface receptor CCR5 expression through manipulation of the cell cycle in activated lymphocytes by administering a composition that arrests the G1 phase of the cell cycle, thereby reducing receptor sites for entry of HIV into T cells, and thus, the effects of HIV. Further, compositions are disclosed that include at least one G1 phase arresting agent and at least one antiviral agent, wherein the combination of agents synergistically enhances the activity of the antiviral agent.